aggression, anxiety, balance issues , blurred vision, brain zaps, concentration impairment, constipation, crying spells, depersonalization, diarrhea, dizziness. electric shock sensations, fatigue, flatulence, flu-like symptoms, hallucinations, hostility, highly emotional, indigestion, irritability, impaired speech, insomnia, jumpy nerves, lack of coordination, lethargy, migraine headaches / increased headaches, nausea, nervousness, over-reacting to situations, paranoia, repetitive thoughts or songs, sensory & sleep disturbances, severe internal restlessness (akathasia), stomach cramps, tremors, tinnitus (ear ringing or buzzing), tingling sensations, troubling thoughts, visual hallucinations / illusions, vivid dreams, speech visual changes, worsened depression

Strattera (Atomoxetine)

Strattera (Atmoxetine) is a Selective Norepinephrine Reuptake Inhibitor approved for the treatment of attention-deficit hyperactivity disorder (ADHD).  In the clinical trials Strattera failed as an antidepressant, and instead was marketed as a non-stimulant treatment for ADHD. Although Strattera was in the same class as Effexor that was not recommended for children due to the risk of suicide, Strattera became the fastest growing ADHD drug and captured a 16% of the market share within 9 months.  It is estimated that nearly one million children were prescribed Strattera in 2003. In September 2005 the FDA found that Strattera may prompt suicidal thoughts in children and the black box warning was required.
Click here for more information on antidepressants...

*Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support. More...